Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Proponents often emphasize the opportunity for meaningful therapeutic benefits, principally in ailments where conventional therapies have proven inadequate. However, crucially important to assess the substantial financial expenditure associated with C